J. Goldman & Co »

Black Diamond Therapeutics shares owned by J. Goldman & Co

Quarter-by-quarter ownership of Black Diamond Therapeutics (BDTX) shares owned by J. Goldman & Co from 13F filings

Historical chart of J. Goldman & Co investment in Black Diamond Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Black Diamond Therapeutics held by J. Goldman & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Black Diamond Therapeutics by J. Goldman & Co

Quarter filed Position value Share count Share price at filing
2025-12-31 $656k 270k 2.43
2025-06-30 $804k 324k 2.48
2025-03-31 $398k 257k 1.55

More positions owned by J. Goldman & Co

Invesco Qqq Tr Unit Ser 1 (QQQ)
Meta Platforms Cl A Call Option (META)
Microsoft Corporation (MSFT)
Honeywell International (HON)
Comcast Corp Cl A (CMCSA)
Western Union Company (WU)
Apple Call Option (AAPL)
Aramark Hldgs (ARMK)
Centuri Holdings Com Shs (CTRI)
Amazon (AMZN)
Gap (GAP)
eBay (EBAY)
Boeing Company (BA)
Sentinelone Cl A (S)
Verra Mobility Corp Cl A Com Stk (VRRM)

View all positions for J. Goldman & Co

Top funds holding Black Diamond Therapeutics

T. Rowe Price Investment Management
NEA Management Company
Vanguard Group
Acadian Asset Management
Marshall Wace
Siren
Arrowstreet Capital, Limited Partnership
Jane Street
Renaissance Technologies
BlackRock
Vestal Point Capital
Dimensional Fund Advisors
Millennium Management
Connor, Clark & Lunn Investment Management
AWM Investment Company

View all funds holding Black Diamond Therapeutics